Moneycontrol PRO

business

Target over 20% revenue growth in FY17: Suven Lifesciences

Venkat Jasti, chairman and chief executive officer, Suven Lifesciences says FY17 looks to be a more promising year and he hopes to log a revenue growth of 20 percent in the same year.

first published: Nov 26, 2015 02:54 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347